DJIA 18,255.37 -30.37 -0.17%
NASDAQ 5,101.62 10.83 0.21%
S&P 500 2,131.65 0.83 0.04%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

42.90 -0.86 (-1.97%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SGEN $42.90 -1.97%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.85
Previous Close $43.76
Daily Range $42.83 - $44.39
52-Week Range $30.05 - $44.95
Market Cap $5.4B
P/E Ratio -66.30
Dividend (Yield) $0.00 (0.0%)
Volume 428,157
Average Daily Volume 1,201,275
Current FY EPS -$0.76




Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website:

News & Commentary

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

4 Momentem Stocks Breaking Out and Poised to Move Higher

First Week of July 17th Options Trading For Seattle Genetics (SGEN)

Insiders new buys : ZU, SGEN, MAC, SHLD, TBRA

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) Is Today's Perilous Reversal Stock

Insider Trading Alert - SGEN, NSP And TSCO Traded By Insiders

Insider Weekends - May 8, 2015

Seattle Genetics director buys more than 1 million shares

Credit Suisse Analysts Assume Coverage On 10 Biotech Stocks

See More SGEN News...

SGEN's Top Competitors

SGEN $42.90 (-1.97%)
Current stock: SGEN
AMGN $163.85 (0.01%)
Current stock: AMGN
GILD $112.47 (1.12%)
Current stock: GILD
BIIB $399.69 (-0.36%)
Current stock: BIIB